Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Published:2021-09-03 Issue:35 Volume:70 Page:1228-1232
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Boehmer Tegan K.,Kompaniyets Lyudmyla,Lavery Amy M.,Hsu Joy,Ko Jean Y.,Yusuf Hussain,Romano Sebastian D.,Gundlapalli Adi V.,Oster Matthew E.,Harris Aaron M.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health(social science),Epidemiology

Reference10 articles.

1. Viral myocarditis—diagnosis, treatment options, and current controversies.;Pollack;Nat Rev Cardiol,2015

2. Myocarditis associated with Covid-19 disease: a systematic review of published case reports and case series.;Rathore;Int J Clin Pract,2021

3. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study.;Murk;CMAJ,2021

4. Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting.;Barda;N Engl J Med,2021

5. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.;Daugherty;BMJ,2021

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital;Biomedicine & Pharmacotherapy;2024-02

2. Cardiovascular effects of the post-COVID-19 condition;Nature Cardiovascular Research;2024-01-18

3. Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae;Viruses;2024-01-14

4. Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents;Annals of Internal Medicine;2024-01-09

5. Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines;Vaccines;2024-01-06